Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-24 @ 7:17 PM
NCT ID:
NCT05894603
Eligibility Criteria:
Inclusion Criteria:
Participants eligible to be included in the study are identified by medical prescribing of one of the drugs under study, and either the medicine recipient or their proxy should:
1. Comply with the eligibility criteria for prescribing these drugs (including patients ≥ 18 years old), according to Norm nr 005/2022 of the General Directorate of Health of Portugal\*;
2. Enrol in the study within the first 72 hours after dispensing treatment;
3. Be able to understand the Portuguese language;
4. Available for follow-up during study time;
5. Provide informed consent.
* Compliance with the eligibility criteria for prescribing these drugs is the sole responsibility of the prescriber who assesses the patient, so the study centres only include patients referred by the prescriber.
Exclusion Criteria:
Will be considered ineligible participants those who:
1. Are not available for follow-up and monitoring;
2. Participate in phase I, II, III or IV clinical trials;
3. Life expectancy is less than one month.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05894603
Study Brief:
Protocol Section:
NCT05894603